This is a phase 3 study to evaluate the effect of Efpeglenatide on cardiovascular outcomes in type 2 diabetes patients at high cardiovascular risk.
1919 State St.
New Albany, IN 47150
Visit ClinicalTrials.gov for more information.
For more information about clinical trials, please call us at 1-317-718-5482 or 1-877-340-7291.